0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  ONLINE FIRST
Vinay Prasad, MD, MPH; Chul Kim, MD, MPH; Mauricio Burotto, MD; et al.
JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2829
Includes: Supplemental Content

Special Communication | 
Gary Schwitzer, BA
JAMA Intern Med. 2014;174(7):1183-1186. doi:10.1001/jamainternmed.2014.1359.
Includes: Supplemental Content

Viewpoint | 
Susan Desmond-Hellmann, MD, MPH
JAMA Intern Med. 2013;173(12):1051-1052. doi:10.1001/jamainternmed.2013.826.

Original Investigation |  FREE
Gregg H. Goldin, MD; Nathan C. Sheets, MD; Anne-Marie Meyer, PhD; et al.
JAMA Intern Med. 2013;173(12):1136-1143. doi:10.1001/jamainternmed.2013.1020.
Includes: Supplemental Content

Invited Commentary | 
Matthew R. Cooperberg, MD, MPH
JAMA Intern Med. 2013;173(12):1143-1144. doi:10.1001/jamainternmed.2013.6755.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Chemotherapy Near the End of Life: First—and Third and Fourth (Line)—Do No Harm
Charles D. Blanke, MD; Erik K. Fromme, MD
JAMA Oncology
Invited Commentary  | 
Physician Estimations of the Risk of Gastrointestinal Stromal Tumor Recurrence—Not Accurate Enough? More Education May Be Needed
Heikki Joensuu, MD
JAMA Oncology
Original Investigation  | 
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Holly G. Prigerson, PhD; Yuhua Bao, PhD; Manish A. Shah, MD; et al.
JAMA Oncology
Original Investigation  | 
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection
Annie Guérin, MSc; Medha Sasane, PhD; Christopher Hunt Keir, MD; et al.